D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
DYN holding history
Dyne Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DYN overviewAll 13F holders of DYNFull Q2 2026 holdings
- Shares (Q2 2026)
- 60,161
- Value
- $1.34M
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 60,161 | $1.34M | <0.1% | +60,161 | New | Holders |
| Q4 2025 | 0 | $0 | 0.0% | −41,587−100.0% | Sold out | Holders |
| Q3 2025 | 41,587 | $526.1K | <0.1% | −467,353−91.8% | Reduced | Holders |
| Q2 2025 | 508,940 | $4.85M | <0.1% | +221,287+76.9% | Added | Holders |
| Q1 2025 | 287,653 | $3.01M | <0.1% | +153,881+115.0% | Added | Holders |
| Q4 2024 | 133,772 | $3.15M | <0.1% | +60,732+83.1% | Added | Holders |
| Q3 2024 | 73,040 | $2.62M | <0.1% | −15,380−17.4% | Reduced | Holders |
| Q2 2024 | 88,420 | $3.12M | <0.1% | +88,420 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −23,668−100.0% | Sold out | Holders |
| Q1 2023 | 23,668 | $272.7K | <0.1% | +10,422+78.7% | Added | Holders |
| Q4 2022 | 13,246 | $153.5K | <0.1% | +13,246 | New | Holders |